SCHEMBL29664346

SCHEMBL29664346

Cc1ccc(-n2cc(Nc3ccccc3)cn2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.53
EGFR P00533 4/20 0.49
FGFR1 P11362 4/20 0.49
KDR P35968 4/20 0.49
MAPT P10636 3/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GAA P10253 2/20 0.42
NPSR1 Q6W5P4 1/20 0.41
CDK19 Q9BWU1 1/20 0.40
ALK Q9UM73 1/20 0.40
HTT P42858 1/20 0.40
CYP1A2 P05177 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM5B Q9UGL1 1/20 0.39
AURKA O14965 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29664327 0.88 GAA (0.53) HPGDEGFRFGFR1KDRMAPT
SCHEMBL29664287 0.84 DRD2 (0.46) NPC1ALDH1A1RAB9AGAAMEN1
SCHEMBL29664147 0.83 EGFR (0.52) EGFRFGFR1KDRMAPTKDM4E
SCHEMBL29664519 0.82 GAA (0.43) EGFRFGFR1KDRMAPTALDH1A1
Diphenylamine SCHEMBL9215415 0.74 HPGD (0.94) HPGDMAPTNPC1ALDH1A1RAB9A
SCHEMBL19248968 0.74 GAA (0.53) HPGDEGFRFGFR1KDRMAPT
SCHEMBL7028384 0.73 MAPT (0.47) HPGDMAPTKDM4ENPC1ALDH1A1
SCHEMBL24137168 0.72 HPGD (1.00) HPGDMAPTNPC1ALDH1A1RAB9A
SCHEMBL172875 0.72 HPGD (1.00) HPGDMAPTNPC1ALDH1A1RAB9A
SCHEMBL9461706 0.72 HPGD (1.00) HPGDMAPTNPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728909-A Composition for preventing or treating cancer comprising novel trifluoromethylphenylpyrazole derivative as active ingredient 韩国原子力医学院 2022-07-08 CN disclosed